Owner Onyx Therapeutics, Inc.

Inventors Shenk, Kevin D.; Parlati, Francesco; Bennett, Mark K.

Agent Shelston IP

Pub. Number AU-A-2011223795

PCT Pub. Number WO2011/109355

Priority 61/309,366 01.03.10 US

Filing date 1 March 2011

Wipo publication date 9 September 2011

C07D 209/20 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4045

A61K 31/5375 - 1,4-Oxazines, e.g. morpholine

A61P 25/00 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

C07D 295/104 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07F 5/04 Compounds containing elements of the 3rd Group of the Periodic System

C07K 5/065 Peptides having up to four amino acids in a fully defined sequence